EP3277270
SAMSETNINGAR OG AÐFERÐIR TIL AÐ MEÐHÖNDLA BLÓÐLEYSI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.3.2016EP published:
27.10.2021EP application number:
16774184.2
EP translation filed:
1.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
30.3.2036Expiry date:
30.3.2027Next due date:
31.3.2027
Title:
COMPOSITIONS AND METHODS FOR TREATING ANEMIA
Timeline
Today
31.3.2016EP application
27.10.2021EP Publication
1.12.2021Translation submitted
15.1.2022Registration published
30.3.2027Expires
Owner
Name:
Akebia Therapeutics, Inc.Address:
245 First Street, Suite 1100, Cambridge, MA 02142, US
Inventor
Name:
SMITH, AlexanderAddress:
Apex, NC 27539, US
Name:
CHANDORKAR, Gurudatt AjayAddress:
Waltham, MA 02452, US
Name:
ETTE, Ene IkpongAddress:
Framingham, MA 01760, US
Name:
MARONI, Bradley JohnAddress:
Boston, MA 02115, US
Name:
HARTMAN, Charlotte SuzanneAddress:
Carmel, IN 46032, US
Name:
FARZANEH-FAR, RaminAddress:
Brookline, MA 02445, US
Name:
INRIG, Jula KernAddress:
Yorba Linda, CA 92887, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562141420 PDate:
1.4.2015Country:
US
Number:
201562270168 PDate:
21.12.2015Country:
US
Classification
Categories:
A61K 31/16, A61P 7/06, C07D 213/16, A61K 9/20, A61K 9/28, A61K 31/4418, C07D 213/81
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.2.2022
Expires: 30.3.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.2.2023
Expires: 30.3.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.2.2023
Expires: 30.3.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 14.2.2024
Expires: 30.3.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.2.2025
Expires: 30.3.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.3.2026
Expires: 30.3.2027
Payer: Árnason Faktor ehf.